RT Journal Article
SR Electronic
T1 The effect of hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.30.21257203
DO 10.1101/2021.05.30.21257203
A1 Ozasa, Mutsumi
A1 Bychkov, Andrey
A1 Zaizen, Yoshiaki
A1 Tabata, Kazuhiro
A1 Uegami, Wataru
A1 Yamano, Yasuhiko
A1 Kataoka, Kensuke
A1 Johkoh, Takeshi
A1 Mukae, Hiroshi
A1 Kondoh, Yasuhiro
A1 Fukuoka, Junya
YR 2021
UL http://medrxiv.org/content/early/2021/09/08/2021.05.30.21257203.abstract
AB Hypersensitivity pneumonitis (HP) and interstitial pneumonia (IP) have several overlapping characteristics, and a high diagnostic concordance rate of HP is rarely obtained. New guideline, highly influenced by pathology, were devised for its diagnosis. We recently reported that the 2020 HP guideline may result in a possible overdiagnosis of fibrotic HP (fHP) through multidisciplinary discussion. Here, we attempted to investigate the impact of the 2020 HP guideline on the pathological diagnosis of cases previously diagnosed as IP. We classified 247 cases with fibrotic IP diagnoses sourced from 2014–2019 into three categories according to the 2020 HP guideline: typical, probable, and indeterminate HP. The original pathological diagnosis and categorization based on the 2020 HP guideline were compared. The clinical data including serum data and pulmonary function tests were compared among groups. The number of cases that changed to HP from an original diagnosis other than HP based on the guideline was 56 (23%). The clinical data of these cases bore a greater resemblance to cases diagnosed as indeterminate for HP than those diagnosed as typical or probable. The ratio of typical and probable HP to the total cases was significantly lower when using a transbronchial lung cryobiopsy (TBLC). Based on the new guideline, the pathological diagnosis of HP efficiently excluded HP cases but increased the rate of HP diagnosis for cases with fibrotic IP that may not suit an HP diagnosis. Thus, a TBLC may not be useful when imparting findings for fibrotic HP diagnosis using the new criteria.Key messagesWhat is the key question? >Does the 2020 HP Guideline improve pathological diagnosis?What is the bottom line? >By applying the new guideline, about 1/4 of the pathological diagnoses were changed from not chronic HP to probable or typical fHP, but most of the changed cases showed a clinical picture closer to not chronic HP.Why read on? >To understand that simple application of the pathological criteria of the HP guideline may cause a misleading diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Practical Research Project for Rare Intractable Diseases from the Japan Agency for Medical Research and Development and a Grant-in-Aid for the Diffuse Lung Diseases Research Group from the Japanese Ministry of Health, Labor and Welfare.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Nagasaki University Hospital Clinical Research Ethics Committee.(No. 20101918)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, J.F, upon reasonable request.